• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血因子 VIII 抗体的异质性:进一步的免疫化学和生物学研究。

Heterogeneity of factor VIII antibodies: further immunochemical and biologic studies.

作者信息

Hultin M B, London F S, Shapiro S S, Yount W J

出版信息

Blood. 1977 May;49(5):807-17.

PMID:403984
Abstract

Previous studies using immunoneutralization techniques have shown that many factor VIII inhibitors are IgG antibodies of a single light chain type. We have investigated this apparent homogeneity by immunoneutralization assay and liquid isoelectric focusing of inhibitor fractions from five hemophiliacs and two nonhemophiliacs. By immunoneutralization assay, inhibitors from four hemophiliacs and one nonhemophiliac were exclusively k light chain type: the fifth hemophilic inhibitor was predominantly k1 and the second nonhemophilic inhibitor was a mixture of k and gamma. However, heavy chain subtyping of the six predominantly or exclusively k inhibitors showed all to be mixtures of IgG4 and IgG1. By isoelectric focusing, two inhibitors showed multiple peaks of activity between pH 5 and 9. The remaining five showed predominant peaks of activity, which were solely IgGk1 between pH 5.8 and 7, with smaller peaks between pH 7 and 9. The most acidic major peak, focusing at pH 6, was IgG4 in the three cases tested. Two of these acidic peaks neutralized factor VIII more efficiently than other peaks in the same focusing profiles, suggesting greater affinity for factor VIII. These studies demonstrate that factor VIII inhibitors are composed of heterogenous subpopulations of immunoglobulins which can be separated by isoelectric focusing.

摘要

以往利用免疫中和技术开展的研究表明,许多凝血因子VIII抑制剂是单轻链类型的IgG抗体。我们通过免疫中和试验以及对来自五名血友病患者和两名非血友病患者的抑制剂组分进行液相等电聚焦,对这种明显的同质性进行了研究。通过免疫中和试验,来自四名血友病患者和一名非血友病患者的抑制剂均为纯κ轻链类型:第五名血友病患者的抑制剂主要为κ1,第二名非血友病患者的抑制剂是κ和γ的混合物。然而,对六种主要为或全部为κ的抑制剂进行重链亚型分析显示,它们均为IgG4和IgG1的混合物。通过等电聚焦,两种抑制剂在pH 5至9之间呈现多个活性峰。其余五种呈现主要活性峰,在pH 5.8至7之间仅为IgGκ1,在pH 7至9之间有较小的峰。在所检测的三例中,聚焦于pH 6的最酸性主峰为IgG4。在相同的聚焦图谱中,其中两个酸性峰比其他峰更有效地中和凝血因子VIII,表明对凝血因子VIII的亲和力更高。这些研究表明,凝血因子VIII抑制剂由免疫球蛋白的异质亚群组成,可通过等电聚焦进行分离。

相似文献

1
Heterogeneity of factor VIII antibodies: further immunochemical and biologic studies.凝血因子 VIII 抗体的异质性:进一步的免疫化学和生物学研究。
Blood. 1977 May;49(5):807-17.
2
Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
J Lab Clin Med. 1981 Jun;97(6):791-800.
3
An acquired inhibitor to factor VIIIC in a non-hemophiliac: twenty years of observation and characterization.一名非血友病患者体内获得性VIII因子抑制物:二十年的观察与特征分析
Am J Hematol. 1987 Apr;24(4):415-24. doi: 10.1002/ajh.2830240411.
4
Immunochemical characterization of factor VIII inhibitors.凝血因子 VIII 抑制剂的免疫化学特性分析
Prog Clin Biol Res. 1984;150:73-85.
5
The immunological characterization of human antibodies to factor VIII isolated by immuno-affinity chromatography.通过免疫亲和色谱法分离的人抗凝血因子 VIII 抗体的免疫学特性分析。
Thromb Haemost. 1981 Feb 23;45(1):60-4.
6
The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.天然存在的抗凝血因子VIII抗体对凝血因子VIII凝血抗原免疫放射分析的影响。对一名存在因子VIII抑制物的交叉反应物质阳性(CRM+)血友病患者的观察。
J Lab Clin Med. 1981 Jan;97(1):65-71.
7
A potential new procedure for removing anti-factor VIII antibodies from hemophilic plasma.一种从血友病患者血浆中去除抗凝血因子VIII抗体的潜在新方法。
Thromb Res. 1987 Jan 1;45(1):51-7. doi: 10.1016/0049-3848(87)90256-8.
8
Immunological characterization of factor VIII inhibitors by a sensitive micro-ELISA method.
Thromb Res. 1990 Mar 15;57(6):897-908. doi: 10.1016/0049-3848(90)90156-7.
9
[Factor VIII epitopes recognized by inhibitors in hemophiliacs].
Rinsho Ketsueki. 1991 Sep;32(9):945-50.
10
The prevalence of proteolytic antibodies against factor VIII in hemophilia A.甲型血友病中抗凝血因子VIII蛋白水解抗体的患病率。
N Engl J Med. 2002 Feb 28;346(9):662-7. doi: 10.1056/NEJMoa011979.

引用本文的文献

1
Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.实验室检测血友病患者的因子 VIII 和 IX 抑制剂:综述。
Haemophilia. 2018 Mar;24(2):186-197. doi: 10.1111/hae.13424. Epub 2018 Feb 15.
2
Immunologically generated circulating anticoagulants in humans.人类免疫产生的循环抗凝剂。
Surv Immunol Res. 1984;3(1):64-9. doi: 10.1007/BF02918599.
3
Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.系统性红斑狼疮标志物抗体抗Sm的亚类限制和多克隆性。
J Clin Invest. 1985 Apr;75(4):1270-7. doi: 10.1172/JCI111826.